| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 05/11/2011 | CN102056613A Method for preventing corticosteroid usage |
| 05/11/2011 | CN102056609A Pharmaceutical combination |
| 05/11/2011 | CN102051370A Clam cathepsin B gene, encoding protein and application thereof |
| 05/11/2011 | CN102051363A Clam ferroprotein gene as well as coding protein and application of in vitro recombinant expression product of same |
| 05/11/2011 | CN102051343A Bioengineered tissue constructs and methods for producing and using them |
| 05/11/2011 | CN102050847A Extraction and separation method of tannic acid used for curing spontaneous perspiration and night sweat, tannic acid preparation and preparation method of tannic acid preparation |
| 05/11/2011 | CN102049039A Application of p65 in preparation of medicament for up-regulating SIRT1 expression |
| 05/11/2011 | CN102049034A Hoof nail polypeptide preparation for promoting tissue repair and preparation method thereof |
| 05/11/2011 | CN102049019A Traditional Chinese medicine for curing hernia and tunica vaginalis hydrocele |
| 05/11/2011 | CN102048832A Method for preparing refreshing ointment |
| 05/11/2011 | CN101601769B Medicinal composition for treating primiparous hen diseases |
| 05/11/2011 | CN101367761B 6,7- substituted-2,2,4-trimethyl-tetrahydroquinoline-1-carboxylic acid aryl amide, synthesis and uses thereof |
| 05/11/2011 | CN101239061B New purpose of aminoperhydro-quinazoline compounds for eliminating clenbnterol in organisms |
| 05/11/2011 | CN101152295B Aromatic essential oil capable of exciting vitality and enjoying oneself, and uses of the same |
| 05/11/2011 | CN101103032B Bicyclic pyrrole derivatives |
| 05/11/2011 | CN101036706B Wine for promoting blood circulation, removing blood stasis and eliminating rheumatism |
| 05/11/2011 | CN101032486B Medical plants synergist having antifungal activity and drug tolerance of reversion azole antifungal agents |
| 05/10/2011 | USRE42353 Quinazoline derivatives and pharmaceutical compositions containing them |
| 05/10/2011 | US7939670 Nociceptin analogs |
| 05/10/2011 | US7939639 Functional role of adrenomedullin (AM) and the gene related product (PAMP) in human pathology and physiology |
| 05/10/2011 | US7939549 1,2-dihydropyridine compounds, manufacturing method thereof and use thereof |
| 05/10/2011 | US7939522 Dosage formulations for acetylcholinesterase inhibitors |
| 05/10/2011 | US7939494 Method for administering GLP-1 molecules |
| 05/10/2011 | US7939268 Compositions and methods for the diagnosis and treatment of tumor |
| 05/10/2011 | CA2565850C Tetrahydrocarbazole derivatives with biological action and solubility as ligands for g-protein coupled receptors (gpcrs) |
| 05/10/2011 | CA2485535C Modified release pharmaceutical formulation |
| 05/10/2011 | CA2483105C Autoimmune conditions and nadph oxidase defects |
| 05/10/2011 | CA2478335C Amino-methyl substituted tetracycline compounds |
| 05/10/2011 | CA2477004C Novel sustained release pharmaceutical compounds to prevent abuse of controlled substances |
| 05/10/2011 | CA2475498C Piperidine derivative and pharmaceutical composition comprising the same as active ingredient |
| 05/10/2011 | CA2463102C Pyrazolidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors |
| 05/10/2011 | CA2451279C Derivatives of triazolyl-imidazopyridine and of the triazolylpurines useful as ligands of the adenosine a2a receptor and their use as medicaments |
| 05/10/2011 | CA2436935C Serine protease inhibitors |
| 05/10/2011 | CA2433158C Pyridone derivatives having a binding activity to the cannabinoid type 2 receptor |
| 05/10/2011 | CA2419633C Substituted imidazoles as tafia inhibitors |
| 05/10/2011 | CA2411056C Pharmaceutical compositions containing prostacyclin synthase gene |
| 05/10/2011 | CA2406664C Systemic delivery of neural stem cells to treat cancer |
| 05/10/2011 | CA2375605C Peptide leukotriene receptor |
| 05/10/2011 | CA2361249C Enriched central nervous system stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations |
| 05/10/2011 | CA2304810C Tie receptor tyrosine kinase ligand homologues |
| 05/10/2011 | CA2171589C Phosphonomonoester nucleic acids, process for their preparation, and their use |
| 05/05/2011 | WO2011052756A1 Novel 3-hydroxy-5-arylisoxazole derivative |
| 05/05/2011 | WO2011052750A1 Anticancer agent sensitivity-determining marker |
| 05/05/2011 | WO2011052748A1 Method for determining sensitivity to an anticancer agent |
| 05/05/2011 | WO2011052715A1 Modified double-stranded polynucleotide |
| 05/05/2011 | WO2011052668A1 Tissue-regeneration promoter using recruitment of bone marrow mesenchymal stem cells and/or pluripotent stem cells in blood |
| 05/05/2011 | WO2011052628A1 Angiogenesis promoter |
| 05/05/2011 | WO2011052554A1 Novel 5-fluorouracil derivative |
| 05/05/2011 | WO2011051406A1 Sterilization of biodegradable hydrogels |
| 05/05/2011 | WO2011050590A1 Polymorph of 3-(substituteddihydroisoindolinone-2-yl)-2,6-dioxopiperidine, and pharmaceutical compositions thereof |
| 05/05/2011 | US20110107444 Novel poly(adp-ribose) polymerase genes |
| 05/05/2011 | US20110105996 Methods for scar prevention |
| 05/05/2011 | US20110105748 Novel beta-phenyl-alpha-oxysubstituted propionic derivatives: process for its preparation and their use in the preparation of pharmaceutically important compounds |
| 05/05/2011 | US20110105731 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon |
| 05/05/2011 | US20110105614 High Concentration Baclofen Preparations |
| 05/05/2011 | US20110105582 Composition for inhibiting function of human flt3 |
| 05/05/2011 | US20110105572 Carbamic acid compounds comprising an amide linkage as hdac inhibitors |
| 05/05/2011 | US20110105557 Farnesyl protein transferase inhibitor combinations with antiestrogen agents |
| 05/05/2011 | US20110105551 Analgesics for nasal administration |
| 05/05/2011 | US20110105548 N-aryl diazaspirocyclic compounds and methods of preparation and use thereof |
| 05/05/2011 | US20110105547 Filamin a-binding anti-inflammatory analgesic |
| 05/05/2011 | US20110105543 Novel triaryl derivatives useful as modulators of nicotinic acetylcholine receptors |
| 05/05/2011 | US20110105511 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 05/05/2011 | US20110105504 Inhibitors Of 11beta-Hydroxysteroid Dehydrogenase Type 1 |
| 05/05/2011 | US20110105485 Alpha-(N-Sulfonamido)Acetamide Derivatives as Beta-Amyloid Inhibitors |
| 05/05/2011 | US20110105446 Sustained Release Enhanced Lipolytic Formulation for Regional Adipose Tissue Treatment |
| 05/05/2011 | US20110105441 Stable Orally Disintegrating Tablets Having Low Superdisintegrant |
| 05/05/2011 | US20110105435 Therapy option for recoloration of hair via bisphosphonates by physiological repigmentation with age-related and/or premature "grayed" patients |
| 05/05/2011 | US20110105433 Lecithin and lc-pufa |
| 05/05/2011 | US20110105427 Deazapurines and uses thereof |
| 05/05/2011 | US20110105415 Gene regulator |
| 05/05/2011 | US20110105412 Conjugated molecules comprising a peptide derived from the cd4 receptor coupled to a polyanion for the treatment of aids |
| 05/05/2011 | US20110104311 Performance Beverage |
| 05/05/2011 | US20110104276 Pharmaceutical composition containing as an active ingredient 5-methyl-1-phenyl-2-(1h)-pyridone |
| 05/05/2011 | US20110104225 Polypeptides, matrices, hydrogels and methods of using same for tissue regeneration and repair |
| 05/05/2011 | US20110104207 Gyrase inhibitors and uses thereof |
| 05/05/2011 | US20110104142 Formulations of peg-functionalised serine proteases with high concentrations of an aromatic preservative |
| 05/05/2011 | US20110104100 Compositions and methods of stem cell therapy for autism |
| 05/05/2011 | US20110104069 Multi-functional biodegradable particles for selectable targeting, imaging, and therapeutic delivery and use thereof for treating ocular disorders |
| 05/05/2011 | US20110104068 Echogenic Coatings and Their Use in Medical Devices |
| 05/05/2011 | US20110104063 Flexibly labeling peptides |
| 05/05/2011 | US20110104059 Membrane Associated Tumor Endothelium Markers |
| 05/05/2011 | US20110104055 Substituted n-aryl benzamides and related compounds for treatment of amyloid diseases and synucleinopathies |
| 05/05/2011 | US20110104054 Small-Molecule HSP90 Inhibitors |
| 05/05/2011 | CA2779398A1 Novel 3-hydroxy-5-arylisoxazole derivative |
| 05/05/2011 | CA2778759A1 Tissue-regeneration promoter using recruitment of bone marrow mesenchymal stem cells and/or pluripotent stem cells in blood |
| 05/05/2011 | CA2776723A1 Sterilization of biodegradable hydrogels |
| 05/04/2011 | EP2316939A2 Novel peptide |
| 05/04/2011 | EP2316919A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 05/04/2011 | EP2316918A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 05/04/2011 | EP2316470A2 Peptidomimetic inhibitors of post-proline cleaving enzymes |
| 05/04/2011 | EP2316458A1 Pyridazine derivatives for inhibiting human stearoyl-coa-desaturase |
| 05/04/2011 | EP2316457A1 Pyridine derivatives for inhibiting human stearoyl-coa-desaturase |
| 05/04/2011 | EP2316455A1 Pharmaceutical compositions for treating cancer |
| 05/04/2011 | EP2316453A1 Methods of reducing adverse events associated with pirfenidone therapy |
| 05/04/2011 | EP2316450A1 Amino-methyl substituted tetracycline compounds |
| 05/04/2011 | EP2316445A1 HUMAN beta3 ADRENERGIC RECEPTOR LIGAND, AND FOOD OR PHARMACEUTICAL PRODUCT CONTAINING THE SAME |
| 05/04/2011 | EP2315756A2 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase |
| 05/04/2011 | EP2315586A1 1-amino-alkylcyclohexane derivatives for the treatment of sleep disorders |
| 05/04/2011 | EP2128248B1 Oligonucleotide compositions with enhanced efficiency |